119 related articles for article (PubMed ID: 38712509)
21. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
[TBL] [Abstract][Full Text] [Related]
23. From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM/GBSA Study.
Song S; Shao Z
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234712
[TBL] [Abstract][Full Text] [Related]
24. Exploration of Diosmin to Control Diabetes and Its Complications-an In Vitro and In Silico Approach.
Dubey K; Dubey R; Gupta R; Gupta A
Curr Comput Aided Drug Des; 2021; 17(2):307-313. PubMed ID: 32208122
[TBL] [Abstract][Full Text] [Related]
25. (5-Hydroxy-4-oxo-2-styryl-4
Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
[TBL] [Abstract][Full Text] [Related]
26. Prediction of global marginal land resources for Pistacia chinensis Bunge by a machine learning method.
Chen S; Hao M; Qian Y; Ding F; Xie X; Ma T
Sci Rep; 2022 Apr; 12(1):5843. PubMed ID: 35393461
[TBL] [Abstract][Full Text] [Related]
27. Ponalrestat: a potent and specific inhibitor of aldose reductase.
Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
Jung HA; Yoon NY; Kang SS; Kim YS; Choi JS
J Pharm Pharmacol; 2008 Sep; 60(9):1227-36. PubMed ID: 18718128
[TBL] [Abstract][Full Text] [Related]
29. Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation.
Vyas B; Singh M; Kaur M; Bahia MS; Jaggi AS; Silakari O; Singh B
J Mol Graph Model; 2015 Jun; 59():59-71. PubMed ID: 25911954
[TBL] [Abstract][Full Text] [Related]
30. Effect of eriodictyol on glucose uptake and insulin resistance in vitro.
Zhang WY; Lee JJ; Kim Y; Kim IS; Han JH; Lee SG; Ahn MJ; Jung SH; Myung CS
J Agric Food Chem; 2012 Aug; 60(31):7652-8. PubMed ID: 22809065
[TBL] [Abstract][Full Text] [Related]
31. Aldose reductase from human psoas muscle. Purification, substrate specificity, immunological characterization, and effect of drugs and inhibitors.
Morjana NA; Flynn TG
J Biol Chem; 1989 Feb; 264(5):2906-11. PubMed ID: 2492526
[TBL] [Abstract][Full Text] [Related]
32. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
[TBL] [Abstract][Full Text] [Related]
33. Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors.
Shehzad MT; Imran A; Hameed A; Rashida MA; Bibi M; Uroos M; Asari A; Iftikhar S; Mohamad H; Tahir MN; Shafiq Z; Iqbal J
RSC Adv; 2021 May; 11(28):17259-17282. PubMed ID: 35479726
[TBL] [Abstract][Full Text] [Related]
34. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of Nifedipine on aldose reductase delays cataract progression.
Devi AM; Sankeshi V; Ravali A; Bandaru S; Theendra VK; Sagurthi SR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):161-171. PubMed ID: 37395794
[TBL] [Abstract][Full Text] [Related]
36. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
[TBL] [Abstract][Full Text] [Related]
37. Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith.
Ajish KR; Antu KA; Riya MP; Preetharani MR; Raghu KG; Dhanya BP; Radhakrishnan KV
Nat Prod Res; 2015; 29(10):947-52. PubMed ID: 25200721
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate.
Poulsom R
Biochem Pharmacol; 1986 Sep; 35(17):2955-9. PubMed ID: 3091036
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Biological Evaluation of Arylamide Sulphonate Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 and -3 Inhibitors.
Ullah S; Pelletier J; Sévigny J; Iqbal J
ACS Omega; 2022 Aug; 7(30):26905-26918. PubMed ID: 35936461
[TBL] [Abstract][Full Text] [Related]
40. Identification of 9H-purin-6-amine derivatives as novel aldose reductase inhibitors for the treatment of diabetic complications.
Zhu J; Qi G; Kuang Y; Zhao Y; Sun X; Zhu C; Hao X; Han Z
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200043. PubMed ID: 35466439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
